MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.vaccine.2023.05.005

Медицинская библиотека · Vaccine · 2023

Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques.

Choi Youkyung, Lee Grace Sanghee, Li Song, Lee Jeong Woo, Mixson-Hayden Tonya, Woo Jungreem, Xia Dengning, Prausnitz Mark R, Kamili Saleem, Purdy Michael A, Tohme Rania A

СтатьяПеревод в очереди

Аннотация

Vaccination against hepatitis B using a dissolving microneedle patch (dMNP) could increase access to the birth dose by reducing expertise needed for vaccine administration, refrigerated storage, and safe disposal of biohazardous sharps waste. In this study, we developed a dMNP to administer hepatitis B surface antigen (HBsAg) adjuvant-free monovalent vaccine (AFV) at doses of 5 µg, 10 µg, and 20 µg, and compared its immunogenicity to vaccination with 10 µg of standard monovalent HBsAg delivered by intramuscular (IM) injection either in an AFV format or as aluminum-adjuvanted vaccine (AAV). Vaccination was performed on a three dose schedule of 0, 3, and 9 weeks in mice and 0, 4, and 24 weeks in rhesus macaques. Vaccination by dMNP induced protective levels of anti-HBs antibody responses (≥10 mIU/ml) in mice and rhesus macaques at all three HBsAg doses studied. HBsAg delivered by dMNP induced higher anti-HBsAg antibody (anti-HBs) responses than the 10 µg IM AFV, but lower responses than 10 µg IM AAV, in mice and rhesus macaques. HBsAg-specific CD4+ and CD8+ T cell responses were detected in all vaccine groups. Furthermore, we analyzed differential gene expression profiles related to each vaccine delivery group and found that tissue stress, T cell receptor signaling, and NFκB signaling pathways were activated in all groups. These results suggest that HBsAg delivered by dMNP, IM AFV, and IM AAV have similar signaling pathways to induce innate and adaptive immune responses. We further demonstrated that dMNP was stable at room temperature (20 °C-25 °C) for 6 months, maintaining 67 ± 6 % HBsAg potency. This study provides evidence that delivery of 10 µg (birth dose) AFV by dMNP induced protective levels of antibody responses in mice and rhesus macaques. The dMNPs developed in this study could be used to improve hepatitis B birth dose vaccination coverage levels in resource limited regions to achieve and maintain hepatitis B elimination.

Для цитирования: Choi Youkyung, Lee Grace Sanghee, Li Song, Lee Jeong Woo, Mixson-Hayden Tonya, Woo Jungreem, Xia Dengning, Prausnitz Mark R, Kamili Saleem, Purdy Michael A, Tohme Rania A. Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques.. Vaccine. 2023. DOI: 10.1016/j.vaccine.2023.05.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.